美国2021年19岁及以上成人免疫接种推荐程序
At its October 2020 meeting, the Advisory Committee on Immunization Practices (ACIP)* approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2021.…
要点
- ACIP批准2021年成人免疫接种程序。
- Pfizer-BioNTech新冠疫苗临时推荐用于≥16岁人群。
- Moderna新冠疫苗临时推荐用于≥18岁人群。
核心结论
- ACIP批准了2021年美国19岁及以上成人免疫接种推荐程序,并纳入新冠疫苗推荐。
主要发现
- ACIP批准将新冠疫苗推荐纳入儿童、青少年和成人免疫程序。
- ACIP发布Pfizer-BioNTech新冠疫苗用于≥16岁人群的临时推荐。
- ACIP发布Moderna新冠疫苗用于≥18岁人群的临时推荐。
关键数值与推荐
- Pfizer-BioNTech新冠疫苗临时推荐用于年龄≥16岁人群。
- Moderna新冠疫苗临时推荐用于年龄≥18岁人群。
临床怎么用
- 成人免疫接种应遵循ACIP批准的2021年免疫程序,包括新冠疫苗的临时推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
At its October 2020 meeting, the Advisory Committee on Immunization Practices (ACIP)* approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2021. After the Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine by the Food and Drug Administration, ACIP issued an interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years at its December 12, 2020, emergency meeting (1). In addition, ACIP approved an amendment to include COVID-19 vaccine recommendations in the child and adolescent and adult immunization schedules. After Emergency Use Authorization of Moderna COVID-19 vaccine by the Food and Drug Administration, ACIP issued an interim recommendation for use of Moderna COVID-19 vaccine in persons aged ≥18 years at its December 19, 2020, emergency meeting (2).
引用
- Freedman MS, Ault K, Bernstein H, et al. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33571173. doi:10.15585/mmwr.mm7006a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。